NIGMS Feedback Loop Blog – National Institute of General Medical Sciences
A catalyst for interaction with the scientific community
UPDATE: The slides [PDF] and video for this webinar are now available. Are you preparing a grant application for the Bridges to the Baccalaureate (B2B) or the Bridges to the Doctorate (B2D) institutional training program? If so, please join our webinar to learn about the programs and application components. You’ll also have the opportunity to ask questions:
NIGMS maintains a diverse biomedical research portfolio, supporting a wide range of topics and investigators. In Fiscal Year (FY) 2021, NIGMS received a congressional appropriation of $2,991,417,000. As part of the Consolidated Appropriations Act, 2022, this budget increased by 3.4% to $3,092,373,000 for FY 2022. The majority of these funds support research project grants (RPGs) at …
Continue reading “Application and Funding Trends in Fiscal Year 2021”
UPDATE: The video for this webinar are now available. We’re pleased to share that NIGMS has reissued two funding opportunity announcements (FOAs) for our technology development program. Both FOAs support the development of novel technologies with the potential for broad utility in biomedical research. They are: Technology Development Research for Establishing Feasibility and Proof of …
Continue reading “NIGMS Funding Opportunities for Technology Development and Upcoming Webinar”
On December 27, 2020, the Consolidated Appropriations Act, 2021, was signed into law. The appropriation provides NIGMS with a budget of $2,991,417,000, in Fiscal Year (FY) 2021, a 1.8% increase over the FY 2020 appropriation. With this increased budget, NIGMS is committed to providing taxpayers with the best possible returns on their investments in fundamental biomedical research. …
Continue reading “Application and Funding Trends in Fiscal Year 2020”
UPDATE: The funding opportunity, Understanding and Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 Clinical Trial Optional) (RFA-MD-21-004), is now available. A pre-application technical assistance workshop will be held on May 26, 1-2:30 p.m. ET. See NOT-MD-21-018 for details. We want to make you aware of two funding …
Continue reading “Funding Opportunities: Addressing Structural Racism and Discrimination”
Our Division of Training, Workforce Development, and Diversity (TWD) supports programs at multiple career stages to foster the development of a strong and diverse biomedical research workforce. This post is the first in a series focused on data from NIGMS training programs and is similar to the ones we have done for our research project …
We’ve issued a new funding opportunity announcement (FOA): Exploring the Scientific Value of Existing or New Sepsis Human Biospecimen Collections (R21/R33 – Clinical Trial Not Allowed) (PAR-21-077). This FOA aims to promote the optimal use, testing, and sharing of patient-derived materials. It stems from recommendations of the NAGMSC working group on sepsis and input from …
The recent deaths of George Floyd, Ahmaud Arbery, and Breonna Taylor, in addition to the disproportionate burden of COVID-19 on African Americans, are wrenching reminders of the many harms that societal racism, inequality, and injustice inflict on the Black community. These injustices are rooted in centuries of oppression—including slavery and Jim Crow, redlining, school segregation, …
Continue reading “What Can We Do to Combat Anti-Black Racism in the Biomedical Research Enterprise?”
UPDATE: Figure 2 of this post was updated slightly in March 2021 to reflect NIGMS-supported Early Stage Investigator counts more accurately. On December 20, 2019, the Further Consolidated Appropriations Act, 2020 , was signed into law. The appropriation provides NIGMS with a budget of $2,937,218,000 in Fiscal Year (FY) 2020, a 2.2% increase over the FY …
Continue reading “Application and Funding Trends in Fiscal Year 2019”
Ninety percent of the applications to our Maximizing Investigators’ Research Award for Early Stage Investigators (known as the ESI MIRA program) that were submitted in October are about to undergo peer review. The remaining 10% were administratively withdrawn, mostly because the research proposed fell outside the NIGMS mission. This is comparable to the proportion that …
Continue reading “How do I know if my work fits in the mission of NIGMS?”